- Home
- SHO vs TARS Comparison
SHO vs TARS Comparison
Compare SHO & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHO
- TARS
- Stock Information
- Founded
- SHO 1995
- TARS 2016
- Country
- SHO United States
- TARS United States
- Employees
- SHO N/A
- TARS N/A
- Industry
- SHO Hotels/Resorts
- TARS Medicinal Chemicals and Botanical Products
- Sector
- SHO Consumer Discretionary
- TARS Health Care
- Exchange
- SHO Nasdaq
- TARS Nasdaq
- Market Cap
- SHO 2.4B
- TARS 2.1B
- IPO Year
- SHO 1995
- TARS 2020
- Fundamental
- Price
- SHO $11.98
- TARS $55.00
- Analyst Decision
- SHO Hold
- TARS Strong Buy
- Analyst Count
- SHO 5
- TARS 5
- Target Price
- SHO $12.20
- TARS $54.20
- AVG Volume (30 Days)
- SHO 3.4M
- TARS 498.2K
- Earning Date
- SHO 02-21-2025
- TARS 02-25-2025
- Dividend Yield
- SHO 3.00%
- TARS N/A
- EPS Growth
- SHO 89.56
- TARS N/A
- EPS
- SHO 0.76
- TARS N/A
- Revenue
- SHO $910,264,000.00
- TARS $129,621,000.00
- Revenue This Year
- SHO N/A
- TARS $915.42
- Revenue Next Year
- SHO $9.28
- TARS $76.97
- P/E Ratio
- SHO $15.83
- TARS N/A
- Revenue Growth
- SHO N/A
- TARS 801.96
- 52 Week Low
- SHO $9.39
- TARS $18.99
- 52 Week High
- SHO $12.41
- TARS $56.77
- Technical
- Relative Strength Index (RSI)
- SHO 60.28
- TARS 66.54
- Support Level
- SHO $11.80
- TARS $53.01
- Resistance Level
- SHO $12.20
- TARS $56.77
- Average True Range (ATR)
- SHO 0.23
- TARS 2.81
- MACD
- SHO -0.07
- TARS -0.02
- Stochastic Oscillator
- SHO 29.51
- TARS 78.73
About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. Sunstone's sole source of income is hotel revenue from its hotel ownership segment.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.